The companies argue the commissioners have “a lengthy track record of making public statements that indicate serious bias” against pharmacy benefit managers.
More Stories
Bitwise CIO: Three things are needed for Bitcoin’s “melt-up” to $80,000 in Q4
Matt Hougan has said three factors will push Bitcoin to $80,000 by the end of 2024 Hougan indicated that the...
VanEck unveils $30 million fund for crypto and AI startups
VanEck says the new $30 million fund targets startups in crypto, artificial intelligence and fintech. The fund will invest in...
GM expects 2025 earnings to be similar to this year’s despite industry headwinds
The Detroit automaker's targeted adjusted earnings before interest and taxes this year is between $13 billion and $15 billion, or...
SpaceX may receive FAA license for next Starship launch in time for Sunday attempt
The Federal Aviation Administration may issue SpaceX its next Starship license in time for a Sunday launch attempt, CNBC has...
Disneyland hikes ticket prices for its highest-demand days
Disneyland's most in-demand tickets will rise around 6% in cost starting Wednesday.
Bridgit Mendler’s space startup Northwood passes first test, connecting prototype antenna to Planet satellites
Northwood Space, the startup led by Bridgit Mendler, passed its first major development test last week by connecting with Planet...